Wanbury Limited has received two recognitions for workplace safety and employee practices at its active pharmaceutical ingredient (API) manufacturing facilities in Maharashtra and Andhra Pradesh. The company’s Patalganga facility in Maharashtra received the Certificate of Excellence from the National Safety Council for its safety performance for the third consecutive year. Its Tanuku facility in Andhra Pradesh was named a “Best Employer” by the state government in recognition of its employee practices and workplace culture.
The awards recognise the company’s efforts to maintain workplace safety and provide an environment that supports employee welfare. Wanbury said it continues to follow environment, health and safety (EHS) standards and Good Manufacturing Practice (GMP) requirements across its operations.
Mohan Rayana, Director of Wanbury Limited, said employee welfare and safety remained central to the company’s operations. He said the awards recognised the work of the Tanuku and Patalganga teams in maintaining safe, compliant and supportive workplaces. The company intends to continue improving safety standards and employee practices across its facilities.
Wanbury manufactures APIs for customers in India and international markets. Its API products are exported to more than 50 countries, while its branded formulations have a pan-India presence. The company’s manufacturing facilities at Tanuku and Patalganga have approvals from the US Food and Drug Administration (USFDA) and comply with European Union Good Manufacturing Practice (EU GMP) requirements, according to the company.
Established in 1988, Wanbury has a portfolio of APIs used in several therapeutic areas, including diabetes management, depression, pain management, antihistamine and anti-inflammatory treatments. The company is also developing additional products for its pipeline and supplies APIs to leading generic pharmaceutical companies. In its formulations business, Wanbury operates across therapeutic categories such as cough and cold, gynaecology, orthopaedics, nutraceuticals, gastrointestinal treatments, anti-inflammatory medicines and analgesics.
The recognition of its two facilities comes as pharmaceutical manufacturers continue to focus on regulatory compliance, employee safety and consistent production standards. Maintaining these practices is important for facilities supplying APIs to pharmaceutical companies in domestic and global markets.
Wanbury is listed on the National Stock Exchange of India under the symbol WANBURY and on the BSE under scrip code 524212. The company’s operations span API manufacturing and branded formulations, supported by its manufacturing and research capabilities.
Wanbury Limited is an Indian pharmaceutical company established in 1988. It develops and manufactures active pharmaceutical ingredients and branded formulations for domestic and international markets. Its API portfolio covers multiple therapeutic areas, and its products are exported to more than 50 countries. The company has manufacturing facilities at Tanuku in Andhra Pradesh and Patalganga in Maharashtra.